80% Covid immunity lost in 6 months in some after Pfizer shot: US study

The researchers particularly looked at humoral immunity - also called antibody-mediated immunity - to measure the body's defences

Pfizer vaccine
Pfizer vaccine
Press Trust of India
1 min read Last Updated : Sep 07 2021 | 2:16 AM IST
Covid-19 antibodies produced by the Pfizer vaccine decreased more than 80 per cent in senior nursing home residents and their caregivers six months after receiving their second dose, a US study has found.

The research led by Case Western Reserve University and Brown University in the US studied blood samples of 120 nursing home residents and 92 health care workers.

The researchers particularly looked at humoral immunity — also called antibody-mediated immunity — to measure the body's defences against the SARS-CoV-2 virus, which causes Covid-19.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPfizerVaccineVaccination

Next Story